Kei Ando
image

Kei Ando

Director

Kei Ando (Tokyo) joined KKR in 2018 and is a Director on the KKR Capital Markets team. Mr. Ando is responsible for executing debt and equity capital markets activities for KKR portfolio companies in Asia Pacific and Japan. He has worked on a number of financings for companies including Magneti Marelli CK Holdings' (formerly Calsonic Kansei) bolt-on acquisition of Magneti Marelli, PHC Holdings' (formerly Panasonic Healthcare) bolt-on acquisition of the anatomical pathology division of Thermo Fisher, and the bolt-on acquisition of LSI Medience Corporation from Mitsubishi Chemical Holdings. Prior to joining KKR, Mr. Ando was with the investment banking team of Citigroup Global Markets Japan, where he was in charge of financial institution clients and was involved in a number of mergers and acquisitions as well as capital raising projects. He was previously at the corporate advisory division of Shinsei Bank. Mr. Ando holds a B.A. from Waseda University.